Emerging therapies for acute traumatic spinal cord injury

CMAJ. 2013 Apr 2;185(6):485-92. doi: 10.1503/cmaj.121206. Epub 2012 Dec 10.

Authors

Jefferson R Wilson¹, Nicole Forgione, Michael G Fehlings

Affiliation

¹ Department of Surgery, Division of Neurosurgery and Spinal Program, University of Toronto, Toronto, Ont.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

ADP Ribose Transferases / therapeutic use
Botulinum Toxins / therapeutic use
Cell Transplantation
Decompression, Surgical
Hemodynamics
Humans
Hypothermia, Induced
Methylprednisolone Hemisuccinate / therapeutic use
Minocycline / therapeutic use
Neuroprotective Agents / therapeutic use
Riluzole / therapeutic use
Spinal Cord Injuries / physiopathology
Spinal Cord Injuries / surgery
Spinal Cord Injuries / therapy*
Treatment Outcome

Substances

Neuroprotective Agents
Methylprednisolone Hemisuccinate
Riluzole
ADP Ribose Transferases
exoenzyme C3, Clostridium botulinum
Botulinum Toxins
Minocycline